Avanos Medical, Inc.AVNSNYSE
LOADING
|||
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
98.18%
↑ 117% above average
Average (39q)
-565.95%
Historical baseline
Range
High:736.94%
Low:-13544.86%
CAGR
-0.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 98.18% |
| Q2 2025 | -1285.71% |
| Q1 2025 | 101.62% |
| Q4 2024 | -9340.64% |
| Q3 2024 | 138.52% |
| Q2 2024 | 301.03% |
| Q1 2024 | -108.48% |
| Q4 2023 | 390.77% |
| Q3 2023 | 94.58% |
| Q2 2023 | -13544.86% |
| Q1 2023 | -102.97% |
| Q4 2022 | 5.88% |
| Q3 2022 | 41.67% |
| Q2 2022 | 100.00% |
| Q1 2022 | -42.86% |
| Q4 2021 | 128.77% |
| Q3 2021 | -192.41% |
| Q2 2021 | 593.75% |
| Q1 2021 | 83.84% |
| Q4 2020 | -347.50% |
| Q3 2020 | 736.94% |
| Q2 2020 | -178.50% |
| Q1 2020 | 161.54% |
| Q4 2019 | 45.83% |
| Q3 2019 | -41.18% |
| Q2 2019 | 60.47% |
| Q1 2019 | -826.72% |
| Q4 2018 | -151.56% |
| Q3 2018 | -88.00% |
| Q2 2018 | 411.33% |
| Q1 2018 | -134.41% |
| Q4 2017 | 100.00% |
| Q3 2017 | -5.41% |
| Q2 2017 | 37.04% |
| Q1 2017 | 28.57% |
| Q4 2016 | 10.53% |
| Q3 2016 | 35.71% |
| Q2 2016 | -53.33% |
| Q1 2016 | -3.23% |
| Q4 2015 | 103.07% |